[ad_1]
In this context, the dismantling of jobs is envisaged, reports the Handelsblatt, citing business circles. The public health sector, in crisis for some time, is particularly affected aspirin and Claritin. But also in pharmaceutical research and in the agricultural sector combined with Monsanto, the jobs would disappear.
At least in Germany, there will be no problems related to the installation, because the site guarantees concluded with the workers' representatives will continue to apply until at least 2020. However, these do not concern the headquarters of Consumer Health, based in Basel. The austerity program of this division also provides for the sale of small brands that Bayer does not want to continue, writes the newspaper.
For the animal health sector, the Bayer Board of Directors leaves open the option of a sale. However, several interested parties would have already declared themselves for a relatively small branch of 1.6 billion euros, reports the Handelsblatt, citing financial circles.
A spokesman for Bayer did not comment on the report.
FRANKFORT (Dow Jones)
WhatsApp Newsletter
Sources of images: Bayer AG, Arseniy Krasnevsky / Shutterstock, 360b / Shutterstock.com, Bayer
[ad_2]
Source link
